Q2 2025 Holdings
Filed 2025-08-14 | 14 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $467.6M | 16,707,477 | 36.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $442.6M | 6,720,803 | 34.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $255.8M | 31,424,760 | 20.0% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $40.0M | 2,209,471 | 3.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $24.9M | 4,854,443 | 1.9% |
| Merus N V | COM | N5749R100 | $23.8M | 452,527 | 1.9% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $12.7M | 4,126,119 | 1.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $6.2M | 9,105,451 | 0.5% |
| Hookipa Pharma Inc(HOOK) | COM NEW | 43906K209 | $2.4M | 1,875,945 | 0.2% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $1.6M | 5,319,148 | 0.1% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $1.3M | 1,156,689 | 0.1% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $848.5K | 317,789 | 0.1% |
| Ikena Oncology Inc | COM | 45175G108 | $467.1K | 348,534 | 0.0% |
| Barinthus Biotherapeutics PL(BRNS) | ADS | 91864C107 | $92.5K | 99,478 | 0.0% |